| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 12/06/2001 | WO2001092502A1 Cutinase variants |
| 12/06/2001 | WO2001092501A1 Improved nucleic acid modifying enzymes |
| 12/06/2001 | WO2001092500A1 Thermostable reverse transcriptases and uses thereof |
| 12/06/2001 | WO2001092498A1 Novel laccase enzyme and the gene encoding the enzyme |
| 12/06/2001 | WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092492A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | WO2001092490A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
| 12/06/2001 | WO2001092471A1 Heavy-metal binding bacteria and their use in detoxification of heavy metal-contaminated media |
| 12/06/2001 | WO2001092465A2 Maize glutamine synthetase gene promoter |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001092297A2 Regulation of human lgr4-like g protein-coupled receptor |
| 12/06/2001 | WO2001091793A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 12/06/2001 | WO2001091711A1 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001055387A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055313A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001048240A3 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001034647A3 Animal collagens and gelatins |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001032879A3 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001027630A3 Methods to identify compounds that modulate neuronal activity |
| 12/06/2001 | WO2001027150A3 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 12/06/2001 | WO2001022922A3 Engineering antibodies that bind irreversibly |
| 12/06/2001 | WO2001018217A3 Thermus promoters for gene expression |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2000077206A3 The myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 12/06/2001 | US20010049435 Myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | US20010049141 Rapidly dissolving nutritionally complex stable dry powder which can be prepared in variable bulk quantities and can be sterilized by ionizing or ultraviolet irradiation; agglomerating a dry powder nutritive media with a solvent |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049132 The use of subsets of a stock inoculum material, which comprises a concentrate of starter culture organism cells to be propagated and harvessted for direct inoculation of a cultivation medium; foods; feeds; drugs; metabolites, e.g. |
| 12/06/2001 | US20010049129 Containing a recombinant plasmid pVIC40 and deposited on Nov. 19, 1987 in the collection of microorganism cultures at the USSR Antibiotics Rearch Institute under Reg. No. 1867; efficiency; nutrients; feeds; drugs |
| 12/06/2001 | US20010049128 Cultivating a microorganism which produces and excretes an L-amino acid, by adding to the broth L-proline or an L-proline derivative as an osmoprotective agent to suppress the effects on the cells of the hyperosmotic stress |
| 12/06/2001 | US20010049126 Escherichia constructed from a sucrose non-assimilative strain, harboring sucrose-6-phosphotransferase system (sucrose PTS) genes that can produce an amino acid other than threonine; using sucrose as carbon source improves yield |
| 12/06/2001 | US20010049124 Fermentation using as microorganism a polysaccharide negative yeast strain Moniliella, concentrating the unrefined micro-organism-free fermentation culture medium to dry substance, crystallizing; purity, simplification |
| 12/06/2001 | US20010049123 Nucleotide sequences encoding the dapC gene and process for the production of L-lysine |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049120 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 12/06/2001 | US20010049118 Increased protease activity and peptidase activity; such as for soy sauce |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010047966 Filtering sample of digested natural sources such as cells or cell fragments using filter the pore size of which decreases in direction of flow of sample through filter |
| 12/06/2001 | US20010047960 Process for nitrifying denitrifying organic waste water |
| 12/06/2001 | DE10026758A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung corymeformer Bakterien A process for the fermentative preparation of D-pantothenic acid using bacteria corymeformer |
| 12/06/2001 | DE10025620A1 New nucleic acid encoding chimeric potassium channel protein, useful, when immobilized on carrier, in screening agents for toxicity and pharmaceutical activity |
| 12/06/2001 | DE10024569A1 Verfahren zur mikrobiellen Herstellung von Difructoseanhydrid-III, dafür einsetzbarer Mikroorganismus sowie Enzym mit Inulase-II-Aktivität und dafür kodierende DNA-Sequenzen A process for the microbial production of Difructoseanhydrid-III, but usable micro-organism and enzyme with inulase II activity, and DNA sequences coding for |
| 12/06/2001 | DE10017675A1 Verfahren zur Identifizierung und Isolierung von Genomfragmenten mit Kopplungsungleichgewicht A process for the identification and isolation of genomic fragments with linkage disequilibrium |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2410947A1 Methods for mediating gene suppresion by using factors that enhance rnai |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410665A1 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | CA2410591A1 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | CA2410470A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2410087A1 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410033A1 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | CA2409417A1 Improved nucleic acid modifying enzymes |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409193A1 Maize glutamine synthetase gene promoter |
| 12/06/2001 | CA2408406A1 Cutinase variants |
| 12/06/2001 | CA2406939A1 Thermostable reverse transcriptases and uses thereof |
| 12/06/2001 | CA2400777A1 Process for the fermentative preparation of l-threonine |
| 12/05/2001 | EP1160901A2 Process for generating electrical power using a fuel cell |
| 12/05/2001 | EP1160330A1 Substances wk-5344a and wk-5344b and process for producing the same |
| 12/05/2001 | EP1160327A2 Novel proteolytic enzymes and their use in detergents |
| 12/05/2001 | EP1160325A1 Avermectin aglycon synthase genes |
| 12/05/2001 | EP1160324A1 Gene causative of rothmund-thomson syndrome and gene product |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1159951A1 Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases |
| 12/05/2001 | EP1159432A1 Methods for generating and screening novel metabolic pathways |
| 12/05/2001 | EP1159422A1 Compositions and methods for the treatment of tumors |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159412A2 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 12/05/2001 | EP1159402A1 Cells resistant to toxic genes and uses thereof |
| 12/05/2001 | EP1159401A1 Assays for inhibitors of ftsh |
| 12/05/2001 | EP1159400A1 Culture of mycobacteria |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159299A1 Mammalian cytokines; related reagents and methods |
| 12/05/2001 | EP1159287A1 50 human secreted proteins |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159062A1 A vessel for mixing a cell lysate |